SCHEMBL1553383

SCHEMBL1553383

CN(C)C(=O)c1cnc(Cl)cc1C=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
ERN1 O75460 5/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PIK3C3 Q8NEB9 2/20 0.35
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
ATF1 P18846 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NUDT1 P36639 1/20 0.32
CNR2 P34972 1/20 0.32
LRRK2 Q5S007 1/20 0.32
SPR P35270 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903465 0.83 PKM (0.37) ALDH1A1MEN1KMT2AHPGDHTT
SCHEMBL17796556 0.80 ALDH1A1 (0.46) ALDH1A1MEN1KMT2APIK3C3HPGD
SCHEMBL1553030 0.80 NAPRT (0.40) ALDH1A1ERN1KMT2AHPGD
SCHEMBL18054000 0.78 SIRT6 (0.43) ALDH1A1ERN1KMT2A
SCHEMBL16441418 0.78 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APIK3C3HPGD
SCHEMBL29775020 0.77 KDM4E (0.40) ALDH1A1ERN1HTTMAPT
SCHEMBL1552677 0.77 KMT2A (0.41) ALDH1A1MEN1KMT2APIK3C3HPGD
SCHEMBL21887605 0.75 ERN1 (0.45) ALDH1A1ERN1MEN1KMT2AHPGD
SCHEMBL20918679 0.74 LRRK2 (0.47) ALDH1A1MEN1KMT2APIK3C3HPGD
SCHEMBL17796428 0.73 KMT2A (0.50) ALDH1A1MEN1KMT2AGPBAR1ATF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
EP-2102199-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS AstraZeneca AB (SE) 2009-09-23 EP disclosed
WO-2008068470-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2008-06-12 WO disclosed
WO-2008068470-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2008-06-12 WO disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132546-A1 CHEMICAL COMPOUNDS MRPL21, NISCH, ABCB11 ALDH1A1 488/4885ERN1 1911/4885MEN1 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.